121
Participants
Start Date
November 10, 2016
Primary Completion Date
August 21, 2017
Study Completion Date
August 21, 2017
Benralizumab
Benralizumab administered subcutaneously every 4 weeks
Research Site, Albany
Research Site, Miami
Research Site, Canton
Research Site, Minneapolis
Research Site, St Louis
Research Site, Edmond
Research Site, McKinney
Research Site, Plano
Research Site, Boerne
Research Site, San Antonio
Research Site, Northridge
Research Site, Riverside
Research Site, Westminster
Research Site, Winter Park
Research Site, Sherwood Park
Research Site, Ajax
Research Site, Burlington
Research Site, Kanata
Research Site, Mississauga
Research Site, Montreal
Research Site, Montreal
Research Site, Québec
Research Site, Québec
Research Site, Sherbrooke
Research Site, Trois-Rivières
Lead Sponsor
AstraZeneca
INDUSTRY